SUPN - Supernus Pharmaceuticals, Inc.
NASDAQ
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Rockville,
United States
Type: Equity
SUPN price evolution
SUPN
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $75.05 | $94.98 | $24.71 | $462.2 |
| Short term investments | $179.82 | $105.2 | $126.95 | $170.13 |
| Net receivables | $144.16 | $141.76 | $136.56 | $143.57 |
| Inventory | $77.41 | $83.48 | $90.56 | $91.15 |
| Total current assets | $493.11 | $449.36 | $423.54 | $883.34 |
| Long term investments | $16.62 | $25.13 | $37.48 | $54.16 |
| Property, plant & equipment | $13.53 | $13.69 | $14.19 | $14.61 |
| Goodwill & intangible assets | $716.91 | $758.17 | $779.41 | $799.52 |
| Total noncurrent assets | $784.56 | $835.8 | $869.56 | $908.47 |
| Total investments | $196.44 | $130.33 | $164.43 | $224.28 |
| Total assets | $1277.67 | $1285.16 | $1293.1 | $1791.81 |
| Current liabilities | ||||
| Accounts payable | $79.57 | $78.47 | $83.04 | $95.34 |
| Deferred revenue | ||||
| Short long term debt | $480.86 | |||
| Total current liabilities | $290.2 | $287.53 | $252.59 | $731.54 |
| Long term debt | $33.2 | $33.84 | $34.18 | $36.51 |
| Total noncurrent liabilities | $65.96 | $85.44 | $120.6 | $148.11 |
| Total debt | $33.2 | $33.84 | $34.18 | $517.37 |
| Total liabilities | $356.16 | $372.97 | $373.19 | $879.66 |
| Shareholders' equity | ||||
| Retained earnings | $482.56 | $481.39 | $497.36 | $498.19 |
| Other shareholder equity | -$0.59 | -$1.21 | -$1.77 | -$2.33 |
| Total shareholder equity | $921.52 | $912.19 | $919.91 | $912.15 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $75.05 | $93.12 | $203.43 | $288.64 |
| Short term investments | $179.82 | $368.21 | $136.25 | $133.89 |
| Net receivables | $144.16 | $165.5 | $148.93 | $140.9 |
| Inventory | $77.41 | $91.54 | $85.96 | $48.3 |
| Total current assets | $493.11 | $734.15 | $601.59 | $630.4 |
| Long term investments | $16.62 | $93.9 | $119.17 | $350.36 |
| Property, plant & equipment | $13.53 | $44.08 | $52.32 | $58.1 |
| Goodwill & intangible assets | $716.91 | $819.48 | $902.21 | $442.25 |
| Total noncurrent assets | $784.56 | $968.36 | $1087.56 | $873.68 |
| Total investments | $196.44 | $462.11 | $255.41 | $484.25 |
| Total assets | $1277.67 | $1702.51 | $1689.15 | $1504.1 |
| Current liabilities | ||||
| Accounts payable | $79.57 | $10.54 | $9.33 | $6.1 |
| Deferred revenue | ||||
| Short long term debt | $401.97 | |||
| Total current liabilities | $290.2 | $687.96 | $315.38 | $245.1 |
| Long term debt | $33.2 | $36 | $379.25 | $382 |
| Total noncurrent liabilities | $65.96 | $128.35 | $557.92 | $514.14 |
| Total debt | $33.2 | $437.97 | $420.55 | $390.33 |
| Total liabilities | $356.16 | $816.3 | $873.3 | $759.2 |
| Shareholders' equity | ||||
| Retained earnings | $482.56 | $481.25 | $379.92 | $326.5 |
| Other shareholder equity | -$0.59 | -$3.21 | $1.54 | $9 |
| Total shareholder equity | $921.52 | $886.2 | $815.85 | $744.86 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $164.31 | $153.88 | $135.56 | $153.76 |
| Cost of revenue | $19.63 | $19.6 | $21.09 | $23.46 |
| Gross Profit | $144.69 | $134.28 | $114.47 | $130.3 |
| Operating activities | ||||
| Research & development | $23.35 | $22.66 | $24.38 | $21.21 |
| Selling, general & administrative | $81.28 | $82.7 | $86.78 | $85.6 |
| Total operating expenses | $147.2 | $126.14 | $132.06 | $125.13 |
| Operating income | -$2.51 | $8.14 | -$17.59 | $5.18 |
| Income from continuing operations | ||||
| EBIT | $0.99 | $9.89 | -$16.22 | $10.52 |
| Income tax expense | -$0.18 | $25.86 | -$16.3 | -$7.93 |
| Interest expense | $0.91 | $1.5 | ||
| Net income | ||||
| Net income | $1.18 | -$15.98 | -$0.83 | $16.95 |
| Income (for common shares) | $1.18 | -$15.98 | -$0.83 | $16.95 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $607.52 | $667.24 | $579.77 | $520.4 |
| Cost of revenue | $83.78 | $87.22 | $75.06 | $52.46 |
| Gross Profit | $523.74 | $580.02 | $504.71 | $467.94 |
| Operating activities | ||||
| Research & development | $91.59 | $74.55 | $90.47 | $75.96 |
| Selling, general & administrative | $336.36 | $377.22 | $304.76 | $200.68 |
| Total operating expenses | $530.53 | $533.89 | $418.69 | $294.24 |
| Operating income | -$6.79 | $46.12 | $86.03 | $173.7 |
| Income from continuing operations | ||||
| EBIT | $5.18 | $67.81 | $96.6 | $192.4 |
| Income tax expense | $1.45 | $0.03 | $19.75 | $41.7 |
| Interest expense | $2.42 | $7.07 | $23.42 | $23.75 |
| Net income | ||||
| Net income | $1.32 | $60.71 | $53.42 | $126.95 |
| Income (for common shares) | $1.32 | $60.71 | $53.42 | $126.95 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $1.18 | -$15.98 | -$0.83 | $16.95 |
| Operating activities | ||||
| Depreciation | $21.68 | $21.86 | $20.73 | $20.6 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $6.45 | $7.92 | $6.09 | $6.31 |
| Total cash flows from operations | $44.96 | $35.88 | -$18.87 | $49.13 |
| Investing activities | ||||
| Capital expenditures | $0.04 | -$0.15 | -$0.16 | -$0.28 |
| Investments | -$66.02 | $34.78 | $60.45 | $240.06 |
| Total cash flows from investing | -$65.98 | $34.63 | $60.3 | $239.78 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $3.08 | -$0.23 | $1.95 | $1.81 |
| Net borrowings | -$480.86 | $78.36 | ||
| Total cash flows from financing | $1.09 | -$0.23 | -$478.92 | $80.17 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$19.93 | $70.28 | -$437.49 | $369.08 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $1.32 | $60.71 | $53.42 | $126.95 |
| Operating activities | ||||
| Depreciation | $84.86 | $85.54 | $32.59 | $18.14 |
| Business acquisitions & disposals | -$298.8 | -$313.54 | ||
| Stock-based compensation | $26.76 | $17.57 | $17.91 | $16.56 |
| Total cash flows from operations | $111.08 | $116.83 | $127.13 | $138.4 |
| Investing activities | ||||
| Capital expenditures | -$0.55 | -$0.41 | -$2.04 | -$3.45 |
| Investments | $269.28 | -$216.25 | $218.94 | $282.53 |
| Total cash flows from investing | $268.73 | -$216.66 | -$81.91 | -$34.7 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $6.61 | $12.42 | $7.09 | $4.36 |
| Net borrowings | -$402.5 | -$137.51 | -$0.8 | |
| Total cash flows from financing | -$397.88 | -$10.48 | -$130.42 | $3.56 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$18.07 | -$110.31 | -$85.21 | $107.26 |
News
Fundamentals
| Market cap | $1.63B |
|---|---|
| Enterprise value | $1.58B |
| Shares outstanding | 54.72M |
| Revenue | $607.52M |
|---|---|
| EBITDA | $90.04M |
| EBIT | $5.18M |
| Net Income | $1.32M |
| Revenue Q/Q | -1.80% |
| Revenue Y/Y | -8.95% |
| P/E ratio | 1.24K |
|---|---|
| EV/Sales | 2.61 |
| EV/EBITDA | 17.59 |
| EV/EBIT | 305.55 |
| P/S ratio | 2.68 |
| P/B ratio | 1.76 |
| Book/Share | 16.85 |
| Cash/Share | 1.37 |
| EPS | $0.02 |
|---|---|
| ROA | 0.09% |
| ROE | 0.14% |
| Debt/Equity | 0.39 |
|---|---|
| Net debt/EBITDA | 3.12 |
| Current ratio | 1.70 |
| Quick ratio | 1.43 |